Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Mitchells & Butlers plc announced that directors Phil Urban, Tim Jones, and Andrew Freeman were granted options on ordinary shares on December 4, 2025, as part of the FY 2026-2028 Performance Share Plan. Phil Urban received an option for up to 460,091 shares, Tim Jones for up to 97,242 shares (pro-rated due to his retirement), and Andrew Freeman for up to 111,727 shares, all at a price of £2.72 per share.
- 2021 Royalties Projected to Double versus Expected 2020 Royalties - - 2021 EPS Guidance of $1.40 to $1.55 Representing 55%-70% Growth over Expected 2020 EPS - SAN DIEGO, Jan. 11, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today introduced 2021 financial guidance and commented on its outlook for the year.
Posted: Monday, August 5, 2019 3:31 pm BWX Technologies Reports Second Quarter 2019 Results With Solid Revenue and EPS Growth Associated Press | LYNCHBURG, Va.--(BUSINESS WIRE)--Aug 5, 2019-- BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2019 revenue of $471 million, a 7.4% increase compared with $439 million in the second quarter of 2018.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
